U.S. Healthcare Services Stock News

NasdaqGS:POOL
NasdaqGS:POOLRetail Distributors

Does Pool’s (POOL) CEO Transition and Dividend Hike Reveal a Deeper Capital Allocation Shift?

Pool Corporation recently announced that, effective May 4, 2026, John B. Watwood became President and CEO, succeeding Peter D. Arvan, while long-time director John E. Stokely moved into the Executive Chair role and the Board approved a quarterly dividend increase to US$1.30 per share. These leadership changes, alongside the appointment of new director Mark A. Pompa and a higher dividend, signal the Board’s focus on continuity, governance refreshment, and capital returns to...
NYSE:PFE
NYSE:PFEPharmaceuticals

If AI Reshapes Healthcare, These Three Stocks Could Lead

AI in healthcare sits at the crossroads of powerful themes investors are already watching, from inflation and tighter financing conditions to pressure on productivity and public budgets. As energy costs and rates keep policy makers on alert, hospitals, insurers and drug developers are under pressure to do more with less, while patients still want faster, more accurate care. The Transformative AI Healthcare Stocks screener filters for companies using AI to tackle diagnostics, treatment and...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

How Investors May Respond To Atlanta Braves Holdings (BATR.K) Strong Q1 Revenue Amid Continuing Losses

Atlanta Braves Holdings, Inc. has reported past first-quarter 2026 results showing revenue of US$72.01 million versus US$47.21 million a year earlier, with a net loss of US$40.48 million and basic and diluted loss per share of US$0.63. The combination of higher revenue and a slightly narrower loss highlights how the Braves’ media and stadium-driven business model can add scale even while the team remains loss-making. We’ll now examine how this stronger year-over-year revenue performance...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Three High ROE Stocks With Quietly Powerful Balance Sheets

Markets are wrestling with higher inflation, rising bond yields and volatile energy prices, so quality balance sheets matter more than ever. When borrowing costs and policy expectations shift frequently, companies with strong return on equity, resilient past performance and solid finances can give you cleaner exposure to long term growth stories, without relying on heavy leverage or speculative turnarounds. This article focuses on a curated screener that looks exactly for that mix of quality...
NYSE:XPO
NYSE:XPOTransportation

The Bull Case For XPO (XPO) Could Change Following Q1 2026 Earnings Beat And Buyback Completion

XPO, Inc. has already reported its first-quarter 2026 results, with sales of US$2,096 million and net income of US$101 million, alongside completing a US$155 million buyback of 1,114,779 shares announced in March 2025. The combination of stronger earnings, technology-driven efficiency gains in its less-than-truckload operations, and easing fuel costs underlines how XPO is using both operational execution and capital returns to strengthen its freight transportation business. We’ll now examine...
NYSEAM:IE
NYSEAM:IEMetals and Mining

Why Ivanhoe Electric (IE) Is Up 12.2% After Alacrán Sale Boosts Profit And Funds Exploration

Ivanhoe Electric’s first-quarter 2026 results showed sales of US$858,000 and net income of US$41.74 million, a sharp turnaround from a net loss a year earlier, largely reflecting a very large gain from subsidiary Cordoba’s sale of the Alacrán copper-gold project. Alongside this profit swing, Ivanhoe Electric increased exploration spending at assets such as the Santa Cruz Copper Project and entered new copper-focused collaborations, including a partnership with SQM Chile, reshaping how...
NYSE:SON
NYSE:SONPackaging

Will Sonoco’s (SON) ESOP Share Issuance and Earnings Quality Scrutiny Recast Its Profit Narrative?

In late April 2026, Sonoco Products Company filed a US$71.37 million shelf registration for 1,430,000 common shares tied to an ESOP-related offering. While the company recently reported strong earnings, the reliance on unusual items and flagged warning signs has raised questions about the quality and durability of its profit profile. We’ll now explore how the ESOP-related share issuance and questions over earnings quality intersect with Sonoco’s existing investment narrative. Uncover the...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Does Brookfield Infrastructure Partners’ Rising FFO Amid Net Loss Reframe Its Cash-Flow Story for BIP Investors?

Brookfield Infrastructure Partners L.P. reported past first-quarter 2026 results with revenue rising to US$6,301 million from US$5,392 million, while limited partners recorded a net loss of US$86 million versus income of US$26 million and a basic loss per unit of US$0.20 from continuing operations. At the same time, the partnership increased funds from operations per unit by about 10% and affirmed a quarterly cash distribution of US$0.4550 per unit, highlighting the contrast between...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

The Bull Case For Celldex Therapeutics (CLDX) Could Change Following Q1 Loss And Barzolvolimab Milestones

Celldex Therapeutics recently reported first-quarter 2026 results, with revenue falling to US$15,000 from US$695,000 a year earlier and net loss widening to US$78.69 million, while accelerating investment in late-stage development of its lead antibody barzolvolimab. At the same time, Celldex completed Phase 3 enrollment for barzolvolimab in chronic spontaneous urticaria six months ahead of plan and raised about US$345 million in a follow-on offering, extending its funding runway for ongoing...
NasdaqGM:NBN
NasdaqGM:NBNBanks

A Look At Northeast Bank (NBN) Valuation After Strong Year Over Year Earnings Growth

Key earnings details from Northeast Bank’s latest report Northeast Bank (NBN) posted third quarter results that highlighted year over year changes in profitability, including net interest income of US$63.07 million and net income of US$29.85 million for the period ended March 31, 2026. For the first nine months of the fiscal year, the bank reported net interest income of US$160.07 million and net income of US$73.14 million, giving investors fresh data to assess recent performance and earnings...
NYSE:PCOR
NYSE:PCORSoftware

A Look At Procore Technologies (PCOR) Valuation After Strong Q1 2026 Results And Raised Guidance

Procore Technologies (PCOR) is back in focus after its first quarter 2026 update, which combined higher revenue, a narrower net loss, raised full year guidance, fresh AI moves, and active share repurchases. See our latest analysis for Procore Technologies. Despite the stronger first quarter story and raised 2026 guidance, Procore Technologies' share price return is down 23.9% year to date and total shareholder return is down 26.2% over the past year. The 1 month share price return of 12.9%...
NYSE:AGBK
NYSE:AGBKBanks

Is AGI (AGBK) Offering A Rare Opportunity After A 34.8% Year To Date Slide?

Wondering whether AGI at around US$7.01 is a bargain or a value trap? This article walks through the key valuation clues that can help you frame that question. Over the last week the stock gained 2.9%, while over the past month it fell 1.3% and year to date it is down 34.8%. This naturally raises questions about how the market is currently pricing its prospects and risks. Recent coverage has focused on AGI's position in the US banking sector and how its share price has reacted to shifts in...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

RadNet (RDNT) Q1 Loss Widens Again And Tests Bullish AI Margin Narrative

RadNet Q1 2026 earnings: revenue expands while margins stay under pressure RadNet (RDNT) opened 2026 with Q1 revenue of US$575.6 million and a basic EPS loss of US$0.43, as the stock trades around US$58.19. The company has seen revenue move from US$471.4 million in Q1 2025 to US$575.6 million in Q1 2026, while quarterly EPS has shifted from a loss of US$0.51 to a loss of US$0.43 over the same period. This sets up a results season where investors are watching how quickly revenue scale can...
NasdaqGS:STRA
NasdaqGS:STRAConsumer Services

Does AI-Driven Efficiency Amid Softer Enrollment Change The Bull Case For Strategic Education (STRA)?

In its latest quarter, Strategic Education reported mixed results as weaker U.S. enrollment contrasted with improved profitability driven by cost controls and AI-related efficiencies. An interesting takeaway is how AI-enabled operational gains and expense discipline supported earnings even as core enrollment trends showed signs of strain. Next, we'll examine how these AI-driven efficiency gains, alongside softer enrollment, may reshape the existing investment narrative for Strategic...
NYSE:ONON
NYSE:ONONLuxury

Lazard And 2 Stocks That May Be Trading Below Their Estimated Value

Over the last 7 days, the United States market has risen by 2.2%, contributing to a significant 31% increase over the past year, with earnings forecasted to grow by 17% annually. In such a robust environment, identifying stocks that may be trading below their estimated value can offer investors potential opportunities for growth and diversification.
NYSE:RYAN
NYSE:RYANInsurance

Clover Health Investments And 2 Other Insider Picks For Growth

Over the last 7 days, the United States market has risen by 2.2%, contributing to a substantial 31% climb over the past year, with earnings expected to grow by 17% annually. In such an environment, stocks with high insider ownership can be appealing as they often indicate confidence from those closest to the company’s operations and potential for growth, making them noteworthy considerations for investors seeking opportunities in this thriving market.
NasdaqGS:OPK
NasdaqGS:OPKHealthcare

Spotlight On Promising Penny Stocks For May 2026

Over the last 7 days, the United States market has risen by 2.2%, and over the past year, it has increased by 31%, with earnings forecasted to grow annually by 17%. In light of these conditions, investors may find value in smaller or newer companies that offer growth potential at lower price points. Penny stocks, though an outdated term, still represent a viable investment area for those seeking opportunities in companies with strong financial health and long-term potential.